Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · July 11, 2023

Efficacy of OnabotulinumtoxinA in Improving Oral Aperture in Patients With Scleroderma

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A small clinical trial
J Am Acad Dermatol 2023 Jun 08;[EPub Ahead of Print], CD Gonzalez, JJ Pamatmat, KM Burningham, M Yang, HW Goff

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading